JP2023543131A5 - - Google Patents
Info
- Publication number
- JP2023543131A5 JP2023543131A5 JP2023513670A JP2023513670A JP2023543131A5 JP 2023543131 A5 JP2023543131 A5 JP 2023543131A5 JP 2023513670 A JP2023513670 A JP 2023513670A JP 2023513670 A JP2023513670 A JP 2023513670A JP 2023543131 A5 JP2023543131 A5 JP 2023543131A5
- Authority
- JP
- Japan
- Prior art keywords
- hydroxypropyl
- cyclodextrin
- administration
- therapeutically effective
- amount
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063071257P | 2020-08-27 | 2020-08-27 | |
| US63/071,257 | 2020-08-27 | ||
| PCT/US2021/048084 WO2022047249A1 (en) | 2020-08-27 | 2021-08-27 | Methods for the treatment of cardiovascular disease with cyclodextrins |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023543131A JP2023543131A (ja) | 2023-10-13 |
| JP2023543131A5 true JP2023543131A5 (cg-RX-API-DMAC10.html) | 2024-08-13 |
Family
ID=80353287
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023513670A Pending JP2023543131A (ja) | 2020-08-27 | 2021-08-27 | シクロデキストリンによる心血管疾患の治療方法 |
Country Status (14)
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4877778A (en) * | 1987-07-01 | 1989-10-31 | The Children's Medical Center Corporation | Method of enhancing lipophile transport using cyclodextrin derivatives |
| WO2013155485A2 (en) * | 2012-04-13 | 2013-10-17 | Alessia Fornoni | Method of using cyclodextrin |
-
2021
- 2021-08-27 CA CA3189915A patent/CA3189915A1/en active Pending
- 2021-08-27 JP JP2023513670A patent/JP2023543131A/ja active Pending
- 2021-08-27 MX MX2023002418A patent/MX2023002418A/es unknown
- 2021-08-27 WO PCT/US2021/048084 patent/WO2022047249A1/en not_active Ceased
- 2021-08-27 EP EP21862882.4A patent/EP4203974A4/en active Pending
- 2021-08-27 IL IL300805A patent/IL300805A/en unknown
- 2021-08-27 KR KR1020237010388A patent/KR20230104119A/ko not_active Withdrawn
- 2021-08-27 US US18/023,325 patent/US20240000826A1/en active Pending
- 2021-08-27 AU AU2021331487A patent/AU2021331487A1/en not_active Abandoned
- 2021-08-27 PE PE2023000716A patent/PE20231169A1/es unknown
- 2021-08-27 CN CN202180053234.0A patent/CN116322644A/zh active Pending
- 2021-08-27 CR CR20230135A patent/CR20230135A/es unknown
-
2022
- 2022-11-11 US US17/985,762 patent/US20230091966A1/en not_active Abandoned
-
2023
- 2023-02-27 JO JOJO/P/2023/0043A patent/JOP20230043A1/ar unknown
- 2023-03-23 CO CONC2023/0003656A patent/CO2023003656A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Cutler et al. | Long-term safety and tolerability of iloperidone: results from a 25-week, open-label extension trial | |
| JP2025096283A5 (cg-RX-API-DMAC10.html) | ||
| JP2021502392A5 (cg-RX-API-DMAC10.html) | ||
| JP2022535127A5 (cg-RX-API-DMAC10.html) | ||
| JP2023501457A5 (cg-RX-API-DMAC10.html) | ||
| CN114728012A (zh) | 用于治疗癫痫持续状态的加奈索酮 | |
| JP2022533968A5 (cg-RX-API-DMAC10.html) | ||
| EP3982967A1 (en) | Methods for treating pulmonary arterial hypertension | |
| JP2014185161A (ja) | シロスタゾールを含むカルボスチリル誘導体の脂肪肝治療剤 | |
| TW202617156A (zh) | 用於治療進行性纖維化間質性肺病之新穎口服醫藥組合物及劑量療法 | |
| US20250213504A1 (en) | Methods of intravenously administering sotalol hydrochloride for the treatment of pediatric patients | |
| AU2004275567B2 (en) | Therapeutic treatment | |
| JP2023543133A5 (cg-RX-API-DMAC10.html) | ||
| JP2024520020A5 (cg-RX-API-DMAC10.html) | ||
| JP2023541170A5 (cg-RX-API-DMAC10.html) | ||
| JP2011502112A (ja) | 抗ガン治療の副作用を治療するための新規組成物 | |
| JP2020045332A (ja) | 慢性便秘症を治療するための医薬組成物 | |
| CN113975276B (zh) | 考比替尼在制备治疗缺血/再灌注损伤药物及细胞保护药物中的应用 | |
| JP6420923B1 (ja) | 医薬 | |
| WO2019004465A1 (ja) | ペマフィブラートを含有する医薬 | |
| CN104000814B (zh) | 一种防治痛风性关节炎的药物组合物及其用途 | |
| WO2022238884A1 (en) | Dosing regimens | |
| JP2025508660A5 (cg-RX-API-DMAC10.html) | ||
| US20240358726A1 (en) | Specific therapeutic medical marijuana doses for stress and pain | |
| AU2008201290B2 (en) | Therapeutic treatment |